Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.
作者信息
Elshaer Sally L, Lorys Renee E, El-Remessy A B
机构信息
Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia 30912, USA.
出版信息
Obes Control Ther. 2016;3(1). doi: 10.15226/2374-8354/3/1/00121. Epub 2016 Sep 15.
Abstract
摘要
相似文献
1
Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.细胞疗法与严重肢体缺血：肥胖症中的证据与机遇窗口
Obes Control Ther. 2016;3(1). doi: 10.15226/2374-8354/3/1/00121. Epub 2016 Sep 15.
2
Arginine pretreatment enhances circulating endothelial progenitor cell population and attenuates inflammatory response in high-fat diet-induced obese mice with limb ischemia.精氨酸预处理增强高脂饮食诱导的肥胖伴有肢体缺血小鼠循环内皮祖细胞群体并减轻炎症反应。
Nutr Res. 2018 May;53:67-76. doi: 10.1016/j.nutres.2018.03.010. Epub 2018 Mar 23.
3
Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.严重肢体缺血的细胞治疗：两种细胞治疗产品的综合分析
Cytotherapy. 2017 Feb;19(2):299-310. doi: 10.1016/j.jcyt.2016.10.013. Epub 2016 Nov 30.
4
[Cell therapy of critical lower limb ischemia (problems and prospects)].[严重下肢缺血的细胞治疗（问题与前景）]
Vestn Ross Akad Med Nauk. 2013(3):33-44. doi: 10.15690/vramn.v68i3.598.
5
Progenitor cell therapy in patients with critical limb ischemia without surgical options.无手术选择的严重肢体缺血患者的祖细胞治疗
Ann Surg. 2008 Mar;247(3):411-20. doi: 10.1097/SLA.0b013e318153fdcb.
6
Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia.自体单核干细胞应用于严重肢体缺血患者保肢术后不对称二甲基精氨酸及氧化应激的改善
Stem Cell Res Ther. 2017 Jul 12;8(1):165. doi: 10.1186/s13287-017-0622-2.
7
Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.生长因子、细胞和纳米载体对后肢缺血的三联拯救：从基础到临床试验
Can J Physiol Pharmacol. 2017 Oct;95(10):1125-1140. doi: 10.1139/cjpp-2016-0713. Epub 2017 Apr 13.
8
9
Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia.氯吡格雷和替格瑞洛在严重肢体缺血患者中的治疗窗
J Cardiovasc Pharmacol Ther. 2020 Mar;25(2):158-163. doi: 10.1177/1074248419877411. Epub 2019 Sep 24.
10
An injectable elastin-based gene delivery platform for dose-dependent modulation of angiogenesis and inflammation for critical limb ischemia.一种可注射的基于弹性蛋白的基因传递平台，可实现对关键肢体缺血的血管生成和炎症的剂量依赖性调节。
Biomaterials. 2015 Oct;65:126-39. doi: 10.1016/j.biomaterials.2015.06.037. Epub 2015 Jun 26.
引用本文的文献
1
miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia.miR-210 增强骨髓源性循环促血管生成细胞在肢体缺血情况下的治疗潜力。
Mol Ther. 2018 Jul 5;26(7):1694-1705. doi: 10.1016/j.ymthe.2018.06.003. Epub 2018 Jun 15.
2
Deletion of TXNIP Mitigates High-Fat Diet-Impaired Angiogenesis and Prevents Inflammation in a Mouse Model of Critical Limb Ischemia.TXNIP缺失减轻高脂饮食损害的血管生成并预防严重肢体缺血小鼠模型中的炎症。
Antioxidants (Basel). 2017 Jun 29;6(3):47. doi: 10.3390/antiox6030047.
本文引用的文献
1
Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.改善人间充质干细胞免疫抑制特性的策略。
Stem Cell Res Ther. 2015 Oct 7;6:179. doi: 10.1186/s13287-015-0178-y.
2
p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia.p75神经营养因子受体依赖性核因子κB激活调节糖尿病肢体缺血后的微小RNA-503转录和周细胞-内皮细胞相互作用。
Nat Commun. 2015 Aug 13;6:8024. doi: 10.1038/ncomms9024.
3
Modulating the vascular response to limb ischemia: angiogenic and cell therapies.调节肢体缺血的血管反应：血管生成和细胞疗法。
Circ Res. 2015 Apr 24;116(9):1561-78. doi: 10.1161/CIRCRESAHA.115.303565.
4
The potential and challenges of using stem cells for cardiovascular repair and regeneration.使用干细胞进行心血管修复和再生的潜力与挑战。
Genes Dis. 2014 Sep 1;1(1):113-119. doi: 10.1016/j.gendis.2014.07.003.
5
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.代谢综合征：深入审视这一日益蔓延的流行病及其相关病理状况。
Obes Rev. 2015 Jan;16(1):1-12. doi: 10.1111/obr.12229. Epub 2014 Nov 18.
6
Hind limb ischemia-reperfusion injury in diet-induced obese mice.饮食诱导肥胖小鼠的后肢缺血再灌注损伤。
J Surg Res. 2014 Aug;190(2):683-91. doi: 10.1016/j.jss.2014.01.020. Epub 2014 Jan 17.
7
Prevalence of childhood and adult obesity in the United States, 2011-2012.美国儿童和成人肥胖率，2011-2012 年。
JAMA. 2014 Feb 26;311(8):806-14. doi: 10.1001/jama.2014.732.
8
The current state of stem cell therapy for peripheral artery disease.目前外周动脉疾病的干细胞治疗现状。
Curr Cardiol Rep. 2014 Feb;16(2):447. doi: 10.1007/s11886-013-0447-2.
9
Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.间充质干细胞与间充质干细胞联合脐血治疗自体造血干细胞移植后植入失败：一项前瞻性、开放标签、随机试验的初步研究。
Biol Blood Marrow Transplant. 2014 Feb;20(2):236-42. doi: 10.1016/j.bbmt.2013.11.002. Epub 2013 Nov 8.
10
Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.增强型人骨髓间充质干细胞治疗性血管生成在小鼠后肢缺血模型中的作用。
Regen Med. 2013 May;8(3):283-93. doi: 10.2217/rme.13.17.
Zotero 插件